Amgen Inc Revenue per Employee (AMGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amgen Inc   (NASDAQ: AMGN)
 

Amgen Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.45% in the third quarter 2026, year on year to cumulative value of $38,903 million, Amgen Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,992,538, this marks a new company high.
Within the Healthcare sector Employees of 19 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 313, from total ranking in previous quarter at 413. Amgen Inc has 13,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMGN Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 8.45 % 9.53 % 5.76 % 8.58 % 12.4 %
Sales per Employee (TTM) $ 2,992,538 2,930,385 2,863,077 2,827,000 2,767,000
AMGN's Total Ranking # 313 # 413 # 325 # 332 # 336
Seq. Revenue Change 3.09 % 16.66 % -12.65 % 3.23 % 4.12 %

AMGN Company Profile >> Back to AMGN Efficiency Comparisons >> Compare AMGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 20
Overall Market # 313

Revenue per Employee Statistics
High Average Low
$ 2,992,538 $ 1,668,976 $ 928,308
(Sep 30 2026)   (Sep. 30, 2005)



Financial Statements
Amgen Inc 's Revenue MRQ $ 10,365 Millions Visit AMGN's Income Statement
Amgen Inc 's Revenues TTM $ 38,903 Millions Visit AMGN's aggregate revenue growth
What are AMGN's Sales? Visit AMGN's Sales by Segment




Other Ratios
Amgen Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AMGN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AMGN's Competitors
Revenue per Employee for AMGN's Suppliers
Revenue per Employee for AMGN's Customers

You may also want to know
AMGN's Sales Growth Rates AMGN's Pe Price to earnings ratio AMGN's Receivables Turnover Ratio AMGN's Stock Quote
AMGN's Net Income Growth Rates AMGN's Ps Price to Sales ratio AMGN's Sales per Employee AMGN's Asset Turnover Ratio
AMGN's Net Margin AMGN's Pb Price to Book ratio AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
Date modified: 2026-11-10T11:46:15+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 
Liquidia Corporation  2,879,004.63 $ 621.865  Million 216 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.